Clinical Trial Update: Reduced Intensity AlloSCT in(CML) With Persistent Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating reduced-intensity allogeneic stem cell transplantation for chronic myeloid leukemia with persistent disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Columbia University | Conditions: Chronic Myeloid Leukemia | Phase 2 | Status: TERMINATED